ARGENX SE (1AE.DE) Stock Fundamental Analysis
Europe - Frankfurt Stock Exchange - FRA:1AE - NL0010832176 - Common Stock
780.6 EUR
+9 (+1.17%)
1AE gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 81 industry peers in the Biotechnology industry. While 1AE has a great health rating, its profitability is only average at the moment. 1AE is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year 1AE was profitable.
In the past year 1AE had a positive cash flow from operations.
In the past 5 years 1AE reported 4 times negative net income.
1AE had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
The Return On Assets of 1AE (17.84%) is better than 90.12% of its industry peers.
1AE's Return On Equity of 21.00% is amongst the best of the industry. 1AE outperforms 88.89% of its industry peers.
The Return On Invested Capital of 1AE (5.36%) is better than 79.01% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 17.84% | ||
| ROE | 21% | ||
| ROIC | 5.36% |
ROA(3y)-5.23%
ROA(5y)N/A
ROE(3y)-5.76%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
1AE's Profit Margin of 41.97% is amongst the best of the industry. 1AE outperforms 93.83% of its industry peers.
1AE has a Operating Margin of 15.30%. This is amongst the best in the industry. 1AE outperforms 83.95% of its industry peers.
The Gross Margin of 1AE (89.40%) is better than 80.25% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 15.3% | ||
| PM (TTM) | 41.97% | ||
| GM | 89.4% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), 1AE is destroying value.
1AE has more shares outstanding than it did 1 year ago.
1AE has a worse debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 32.44 indicates that 1AE is not in any danger for bankruptcy at the moment.
The Altman-Z score of 1AE (32.44) is better than 96.30% of its industry peers.
The Debt to FCF ratio of 1AE is 0.14, which is an excellent value as it means it would take 1AE, only 0.14 years of fcf income to pay off all of its debts.
1AE has a better Debt to FCF ratio (0.14) than 91.36% of its industry peers.
1AE has a Debt/Equity ratio of 0.01. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of 1AE (0.01) is better than 83.95% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.01 | ||
| Debt/FCF | 0.14 | ||
| Altman-Z | 32.44 |
ROIC/WACC0.72
WACC7.43%
2.3 Liquidity
1AE has a Current Ratio of 5.60. This indicates that 1AE is financially healthy and has no problem in meeting its short term obligations.
1AE has a Current ratio of 5.60. This is in the better half of the industry: 1AE outperforms 79.01% of its industry peers.
1AE has a Quick Ratio of 5.27. This indicates that 1AE is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 5.27, 1AE belongs to the best of the industry, outperforming 80.25% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 5.6 | ||
| Quick Ratio | 5.27 |
3. Growth
3.1 Past
1AE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 1512.50%, which is quite impressive.
1AE shows a strong growth in Revenue. In the last year, the Revenue has grown by 64.65%.
EPS 1Y (TTM)1512.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%272.66%
Revenue 1Y (TTM)64.65%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%100.85%
3.2 Future
The Earnings Per Share is expected to grow by 107.34% on average over the next years. This is a very strong growth
Based on estimates for the next years, 1AE will show a very strong growth in Revenue. The Revenue will grow by 34.98% on average per year.
EPS Next Y867.29%
EPS Next 2Y297.24%
EPS Next 3Y171.03%
EPS Next 5Y107.34%
Revenue Next Year89.57%
Revenue Next 2Y60.07%
Revenue Next 3Y45.87%
Revenue Next 5Y34.98%
3.3 Evolution
4. Valuation
4.1 Price/Earnings Ratio
1AE is valuated quite expensively with a Price/Earnings ratio of 72.95.
1AE's Price/Earnings ratio is a bit cheaper when compared to the industry. 1AE is cheaper than 77.78% of the companies in the same industry.
1AE is valuated expensively when we compare the Price/Earnings ratio to 26.15, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 33.21 indicates a quite expensive valuation of 1AE.
Compared to the rest of the industry, the Price/Forward Earnings ratio of 1AE indicates a rather cheap valuation: 1AE is cheaper than 80.25% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of 1AE to the average of the S&P500 Index (36.22), we can say 1AE is valued inline with the index average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 72.95 | ||
| Fwd PE | 33.21 |
4.2 Price Multiples
1AE's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. 1AE is cheaper than 74.07% of the companies in the same industry.
79.01% of the companies in the same industry are more expensive than 1AE, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 180.81 | ||
| EV/EBITDA | 102.47 |
4.3 Compensation for Growth
1AE's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
1AE's earnings are expected to grow with 171.03% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.08
PEG (5Y)N/A
EPS Next 2Y297.24%
EPS Next 3Y171.03%
5. Dividend
5.1 Amount
No dividends for 1AE!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
FRA:1AE (12/2/2025, 7:00:00 PM)
780.6
+9 (+1.17%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)
Earnings (Next)
Inst Owners41.51%
Inst Owner ChangeN/A
Ins Owners0.12%
Ins Owner ChangeN/A
Market Cap48.06B
Revenue(TTM)3.60B
Net Income(TTM)1.28B
Analysts84.8
Price Target737.91 (-5.47%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)15.16%
Min EPS beat(2)7.11%
Max EPS beat(2)23.2%
EPS beat(4)3
Avg EPS beat(4)3962.36%
Min EPS beat(4)-38.07%
Max EPS beat(4)15857.2%
EPS beat(8)5
Avg EPS beat(8)1996.71%
EPS beat(12)8
Avg EPS beat(12)1343.38%
EPS beat(16)12
Avg EPS beat(16)1012.62%
Revenue beat(2)1
Avg Revenue beat(2)3.68%
Min Revenue beat(2)-0.81%
Max Revenue beat(2)8.17%
Revenue beat(4)3
Avg Revenue beat(4)3.52%
Min Revenue beat(4)-0.81%
Max Revenue beat(4)8.17%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.25%
PT rev (3m)N/A
EPS NQ rev (1m)-0.95%
EPS NQ rev (3m)N/A
EPS NY rev (1m)6.84%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)2.3%
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 72.95 | ||
| Fwd PE | 33.21 | ||
| P/S | 18.3 | ||
| P/FCF | 180.81 | ||
| P/OCF | 138.25 | ||
| P/B | 9.16 | ||
| P/tB | 9.5 | ||
| EV/EBITDA | 102.47 |
EPS(TTM)10.7
EY1.37%
EPS(NY)23.51
Fwd EY3.01%
FCF(TTM)4.32
FCFY0.55%
OCF(TTM)5.65
OCFY0.72%
SpS42.67
BVpS85.25
TBVpS82.19
PEG (NY)0.08
PEG (5Y)N/A
Graham Number143.26
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 17.84% | ||
| ROE | 21% | ||
| ROCE | 7.61% | ||
| ROIC | 5.36% | ||
| ROICexc | 14.9% | ||
| ROICexgc | 16.54% | ||
| OM | 15.3% | ||
| PM (TTM) | 41.97% | ||
| GM | 89.4% | ||
| FCFM | 10.12% |
ROA(3y)-5.23%
ROA(5y)N/A
ROE(3y)-5.76%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.43
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.01 | ||
| Debt/FCF | 0.14 | ||
| Debt/EBITDA | 0.07 | ||
| Cap/Depr | 428.74% | ||
| Cap/Sales | 3.12% | ||
| Interest Coverage | 519.07 | ||
| Cash Conversion | 82.6% | ||
| Profit Quality | 24.11% | ||
| Current Ratio | 5.6 | ||
| Quick Ratio | 5.27 | ||
| Altman-Z | 32.44 |
F-Score5
WACC7.43%
ROIC/WACC0.72
Cap/Depr(3y)176.19%
Cap/Depr(5y)N/A
Cap/Sales(3y)10.66%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)1512.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%272.66%
EPS Next Y867.29%
EPS Next 2Y297.24%
EPS Next 3Y171.03%
EPS Next 5Y107.34%
Revenue 1Y (TTM)64.65%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%100.85%
Revenue Next Year89.57%
Revenue Next 2Y60.07%
Revenue Next 3Y45.87%
Revenue Next 5Y34.98%
EBIT growth 1Y96.67%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year1305.72%
EBIT Next 3Y205.97%
EBIT Next 5Y122.64%
FCF growth 1Y67.46%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y80.31%
OCF growth 3YN/A
OCF growth 5YN/A
ARGENX SE / 1AE.DE FAQ
What is the ChartMill fundamental rating of ARGENX SE (1AE.DE) stock?
ChartMill assigns a fundamental rating of 6 / 10 to 1AE.DE.
What is the valuation status for 1AE stock?
ChartMill assigns a valuation rating of 5 / 10 to ARGENX SE (1AE.DE). This can be considered as Fairly Valued.
How profitable is ARGENX SE (1AE.DE) stock?
ARGENX SE (1AE.DE) has a profitability rating of 5 / 10.
What is the earnings growth outlook for ARGENX SE?
The Earnings per Share (EPS) of ARGENX SE (1AE.DE) is expected to grow by 867.29% in the next year.